Tiribelli, M.; Michelutti, A.; Cavallin, M.; Di Giusto, S.; Simeone, E.; Fanin, R.; Damiani, D.
BCL-2 Expression in AML Patients over 65 Years: Impact on Outcomes across Different Therapeutic Strategies. J. Clin. Med. 2021, 10, 5096.
https://doi.org/10.3390/jcm10215096
AMA Style
Tiribelli M, Michelutti A, Cavallin M, Di Giusto S, Simeone E, Fanin R, Damiani D.
BCL-2 Expression in AML Patients over 65 Years: Impact on Outcomes across Different Therapeutic Strategies. Journal of Clinical Medicine. 2021; 10(21):5096.
https://doi.org/10.3390/jcm10215096
Chicago/Turabian Style
Tiribelli, Mario, Angela Michelutti, Margherita Cavallin, Sara Di Giusto, Erica Simeone, Renato Fanin, and Daniela Damiani.
2021. "BCL-2 Expression in AML Patients over 65 Years: Impact on Outcomes across Different Therapeutic Strategies" Journal of Clinical Medicine 10, no. 21: 5096.
https://doi.org/10.3390/jcm10215096
APA Style
Tiribelli, M., Michelutti, A., Cavallin, M., Di Giusto, S., Simeone, E., Fanin, R., & Damiani, D.
(2021). BCL-2 Expression in AML Patients over 65 Years: Impact on Outcomes across Different Therapeutic Strategies. Journal of Clinical Medicine, 10(21), 5096.
https://doi.org/10.3390/jcm10215096